Methotrexate with abatacept has little effect on clinical outcomes in RA
KEY POINT
No significant differences in clinical outcomes were observed in patients with rheumatoid arthritis (RA) who were treated with abatacept (Orencia—Bristol-Myers Squibb) with or without concomitant methotrexate (MTX), according to results of a retrospective study published in Clinical Rheumatology.
SOURCES
Takahashi N, et al. Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis. Clin Rheumatol. 2019;[Epub ahead of print].
Singh JA, et al. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1–26.
